Skip to playerSkip to main content
  • 4 years ago
China’s CanSino Biologics has helped Malaysia cross another milestone in vaccine manufacturing, this time by transferring technology to enable the making of the local "fill and finish" CanSino Covid-19 vaccine based on the adenovirus platform.

WATCH MORE: https://thestartv.com/c/news
SUBSCRIBE: https://cutt.ly/TheStar
LIKE: https://fb.com/TheStarOnline

Category

🗞
News
Be the first to comment
Add your comment

Recommended